Continuous Glucose Monitor
Stelo excels in effectiveness (95) due to FDA-validated accuracy equivalent to G7 (MARD ~8-9% per RCTs like PMID:35157505) and extensive CGM evidence base (dozens RCTs/meta-analyses for monitoring). Safety strong (90) with minor AEs in pivotal study and real-world MAUDE data mirroring mature Dexcom platforms. Quality solid (85) via FDA clearance but lacks supplement-style third-party purity certs/COA. Overall 92 reflects proven medtech for OTC wellness glucose tracking.
Stelo is an excellent OTC CGM with FDA-proven accuracy (G7-equivalent MARD ~8%) from pivotal study and RCTs, ideal for non-insulin adults tracking lifestyle glucose impacts. Minor skin risks common to category; superior value at $3/day. Strong recommendation for wellness monitoring.